Compare TRS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRS | PLSE |
|---|---|---|
| Founded | 1986 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2007 | 2016 |
| Metric | TRS | PLSE |
|---|---|---|
| Price | $35.10 | $14.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $41.50 | $22.00 |
| AVG Volume (30 Days) | ★ 410.5K | 156.8K |
| Earning Date | 02-26-2026 | 11-05-2025 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | ★ 68.70 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $1,013,740,000.00 | $86,000.00 |
| Revenue This Year | $1.41 | N/A |
| Revenue Next Year | N/A | $1,002.94 |
| P/E Ratio | $32.33 | ★ N/A |
| Revenue Growth | ★ 11.83 | N/A |
| 52 Week Low | $19.33 | $12.56 |
| 52 Week High | $40.34 | $25.00 |
| Indicator | TRS | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 55.65 |
| Support Level | $33.80 | $13.44 |
| Resistance Level | $35.44 | $14.50 |
| Average True Range (ATR) | 0.87 | 0.73 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 77.72 | 71.25 |
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.